Oct 13, 2020 ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference
Sep 10, 2020 ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Investment Conference
Jul 9, 2020 ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease
Jun 24, 2020 ProMIS Neurosciences announces adjournment and change of location of annual meeting of shareholders
Jun 17, 2020 ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant progress on development of highly accurate antibody test for COVID-19
May 28, 2020 ProMIS Neurosciences and collaborative team receive Supercluster Award supporting avoidance of future pandemics by new strains of the COVID-19 virus
May 20, 2020 ProMIS Neurosciences Chairman’s Update details new programs from expanded use of novel technology platform